Page 1 | Search Results | Molecular Cancer Therapeutics | American Association for Cancer Research

1-7 of 7

Sort by

Sort Order Select

Journal Articles

Abstract B18: Association between apoptotic response and KiSS1 modulation in NSCLC preclinical models treated with SAHA and cisplatin

Laura Gatti, Michelandrea De Cesare, Cristina Corno, Nives Carenini, Elisabetta Corna, Nadia Zaffaroni, Emilio Ciusani, Paola Perego

Mol Cancer Ther (2015) 14 (12_Supplement_2): B18.

https://doi.org/10.1158/1535-7163.TARG-15-B18

Published: 01 December 2015

View article titled, Abstract B18: Association between apoptotic response and KiSS1 modulation in NSCLC preclinical models treated with SAHA and cisplatin

Journal Articles

Abstract A93: Targeting the increased invasive capability of non-small cell lung cancer platinum-resistant cells by histone deacetylase inhibitors.

Valentina Zuco, Giuliana Cassinelli, Giacomo Cossa, Laura Gatti, Enrica Favini, Franco Zunino, Nadia Zaffaroni, Cinzia Lanzi, Paola Perego

Mol Cancer Ther (2013) 12 (11_Supplement): A93.

https://doi.org/10.1158/1535-7163.TARG-13-A93

Published: 01 November 2013

View article titled, Abstract A93: Targeting the increased invasive capability of non-small cell lung cancer platinum-resistant cells by histone deacetylase inhibitors.

Journal Articles

Abstract A64: Synergistic cooperation between sunitinib and cisplatin promotes apoptotic cell death in human medullary thyroid cancer.

Alessia Lopergolo, Valentina Nicolini, Denis Cominetti, Marco Folini, Paola Perego, Vittoria Castiglioni, Eugenio Scanziani, Maria Grazia Borrello, Nadia Zaffaroni, Giuliana Cassinelli, Cinzia Lanzi

Mol Cancer Ther (2013) 12 (11_Supplement): A64.

https://doi.org/10.1158/1535-7163.TARG-13-A64

Published: 01 November 2013

View article titled, Abstract A64: Synergistic cooperation between sunitinib and cisplatin promotes apoptotic cell death in human medullary thyroid cancer.

Journal Articles

Abstract C34: Synergistic interaction between a novel histone deacetylase inhibitor and the proteasome inhibitor bortezomib in platinum-resistant ovarian carcinoma cells.

Laura Gatti, Valentina Benedetti, Michelandrea De Cesare, Elisabetta Corna, Raffaella Cincinelli, Nadia Zaffaroni, Franco Zunino, Paola Perego

Mol Cancer Ther (2011) 10 (11_Supplement): C34.

https://doi.org/10.1158/1535-7163.TARG-11-C34

Published: 12 November 2011

View article titled, Abstract C34: Synergistic interaction between a novel histone deacetylase inhibitor and the proteasome inhibitor bortezomib in platinum-resistant ovarian carcinoma cells.

Journal Articles

Abstract C84: Inhibition of proteasome deubiquitinating activity as a novel cancer therapy.

Padraig D'Arcy, Slavica Brnjic, Maria H. Olofsson, Marten Fryknas, Kristina Lindsten, Michelandrea De Cesare, Paola Perego, Behnam Sadeghi, Moustapha Hassan, Rolf Larsson, Stig T. Linder

Mol Cancer Ther (2011) 10 (11_Supplement): C84.

https://doi.org/10.1158/1535-7163.TARG-11-C84

Published: 12 November 2011

View article titled, Abstract C84: Inhibition of proteasome deubiquitinating activity as a novel cancer therapy.

Journal Articles

Abstract A59: Increased expression of ABC transporter genes in lung cancer CD133‐positive cells

Laura Gatti, Giacomo Cossa, Giulia Bertolini, Monica Tortoreto, Stella Tinelli, Enrico Fontanella, Domenico Delia, Luca Roz, Gabriella Sozzi, Paola Perego

Mol Cancer Ther (2009) 8 (12_Supplement): A59.

https://doi.org/10.1158/1535-7163.TARG-09-A59

Published: 10 December 2009

View article titled, Abstract A59: Increased expression of ABC transporter genes in lung cancer CD133‐positive cells

Journal Articles

Modulation of survival pathways in ovarian carcinoma cell lines resistant to platinum compounds

Valentina Benedetti, Paola Perego, Giovanni Luca Beretta, Elisabetta Corna, Stella Tinelli, Sabina Carla Righetti, Roberto Leone, Piero Apostoli, Cinzia Lanzi, Franco Zunino

Mol Cancer Ther (2008) 7 (3): 679–687.

https://doi.org/10.1158/1535-7163.MCT-07-0450

Published: 17 March 2008

View article titled, Modulation of survival pathways in ovarian carcinoma cell lines resistant to platinum compounds

NARROW

Abstract B18: Association between apoptotic response and KiSS1 modulation in NSCLC preclinical models treated with SAHA and cisplatin

Abstract A93: Targeting the increased invasive capability of non-small cell lung cancer platinum-resistant cells by histone deacetylase inhibitors.

Abstract A64: Synergistic cooperation between sunitinib and cisplatin promotes apoptotic cell death in human medullary thyroid cancer.

Abstract C34: Synergistic interaction between a novel histone deacetylase inhibitor and the proteasome inhibitor bortezomib in platinum-resistant ovarian carcinoma cells.

Abstract C84: Inhibition of proteasome deubiquitinating activity as a novel cancer therapy.

Abstract A59: Increased expression of ABC transporter genes in lung cancer CD133‐positive cells

Modulation of survival pathways in ovarian carcinoma cell lines resistant to platinum compounds

Email alerts

AACR Journals

Abstract B18: Association between apoptotic response and KiSS1 modulation in NSCLC preclinical models treated with SAHA and cisplatin

Abstract A93: Targeting the increased invasive capability of non-small cell lung cancer platinum-resistant cells by histone deacetylase inhibitors.

Abstract A64: Synergistic cooperation between sunitinib and cisplatin promotes apoptotic cell death in human medullary thyroid cancer.

Abstract C34: Synergistic interaction between a novel histone deacetylase inhibitor and the proteasome inhibitor bortezomib in platinum-resistant ovarian carcinoma cells.

Abstract C84: Inhibition of proteasome deubiquitinating activity as a novel cancer therapy.

Abstract A59: Increased expression of ABC transporter genes in lung cancer CD133‐positive cells

Modulation of survival pathways in ovarian carcinoma cell lines resistant to platinum compounds

Email alerts

AACR Journals

This Feature Is Available To Subscribers Only